Both GALNT3 and GALNT6 displayed oncogenic functions in different cancer types; GALNT3 has often been suggested as a possible therapeutic target in pancreatic [19], gastric [20], and colorectal cancers [21]. This evidence concerns the gene GALNT6 and cancer.